These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 9151874)

  • 1. Diminishing adenovirus gene expression and viral replication by promoter replacement.
    Fang B; Koch P; Roth JA
    J Virol; 1997 Jun; 71(6):4798-803. PubMed ID: 9151874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced toxicity, attenuated immunogenicity and efficient mediation of human p53 gene expression in vivo by an adenovirus vector with deleted E1-E3 and inactivated E4 by GAL4-TATA promoter replacement.
    Ji L; Bouvet M; Price RE; Roth JA; Fang B
    Gene Ther; 1999 Mar; 6(3):393-402. PubMed ID: 10435089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of the E4 region on the persistence of transgene expression from adenovirus vectors.
    Armentano D; Zabner J; Sacks C; Sookdeo CC; Smith MP; St George JA; Wadsworth SC; Smith AE; Gregory RJ
    J Virol; 1997 Mar; 71(3):2408-16. PubMed ID: 9032378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Augmenting transgene expression from carcinoembryonic antigen (CEA) promoter via a GAL4 gene regulatory system.
    Koch PE; Guo ZS; Kagawa S; Gu J; Roth JA; Fang B
    Mol Ther; 2001 Mar; 3(3):278-83. PubMed ID: 11273768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term gene delivery into the livers of immunocompetent mice with E1/E4-defective adenoviruses.
    Dedieu JF; Vigne E; Torrent C; Jullien C; Mahfouz I; Caillaud JM; Aubailly N; Orsini C; Guillaume JM; Opolon P; Delaere P; Perricaudet M; Yeh P
    J Virol; 1997 Jun; 71(6):4626-37. PubMed ID: 9151856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Restriction of adenoviral replication to the transcriptional intersection of two different promoters for colorectal and pancreatic cancer treatment.
    Hoffmann D; Wildner O
    Mol Cancer Ther; 2006 Feb; 5(2):374-81. PubMed ID: 16505112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oncolytic adenovirus that overproduces ADP and replicates selectively in tumors due to hTERT promoter-regulated E4 gene expression.
    Kuppuswamy M; Spencer JF; Doronin K; Tollefson AE; Wold WS; Toth K
    Gene Ther; 2005 Nov; 12(22):1608-17. PubMed ID: 16034456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conditional repression of the E2 transcription unit in E1-E3-deleted adenovirus vectors is correlated with a strong reduction in viral DNA replication and late gene expression in vitro.
    Rittner K; Schultz H; Pavirani A; Mehtali M
    J Virol; 1997 Apr; 71(4):3307-11. PubMed ID: 9060700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two leaky-late HSV-1 promoters differ significantly in structural architecture.
    Lieu PT; Wagner EK
    Virology; 2000 Jun; 272(1):191-203. PubMed ID: 10873762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of GAL4/TATA in vivo. Induction of transgene expression by adenovirally mediated gene codelivery.
    Fang B; Ji L; Bouvet M; Roth JA
    J Biol Chem; 1998 Feb; 273(9):4972-5. PubMed ID: 9478943
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased duration of transgene expression in the lung with plasmid DNA vectors harboring adenovirus E4 open reading frame 3.
    Yew NS; Marshall J; Przybylska M; Wysokenski DM; Ziegler RJ; Rafter PW; Li C; Armentano D; Cheng SH
    Hum Gene Ther; 1999 Jul; 10(11):1833-43. PubMed ID: 10446923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A gene transfer vector-cell line system for complete functional complementation of adenovirus early regions E1 and E4.
    Brough DE; Lizonova A; Hsu C; Kulesa VA; Kovesdi I
    J Virol; 1996 Sep; 70(9):6497-501. PubMed ID: 8709289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene product of region E4 of adenovirus type 5 modulates accumulation of certain viral polypeptides.
    Hemström C; Nordqvist K; Pettersson U; Virtanen A
    J Virol; 1988 Sep; 62(9):3258-64. PubMed ID: 2841478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of the Ad5 upstream E1 region and gene products on heterologous promoters.
    Hoffmann D; Jogler C; Wildner O
    J Gene Med; 2005 Oct; 7(10):1356-66. PubMed ID: 15945123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An oncolytic adenovirus selective for retinoblastoma tumor suppressor protein pathway-defective tumors: dependence on E1A, the E2F-1 promoter, and viral replication for selectivity and efficacy.
    Jakubczak JL; Ryan P; Gorziglia M; Clarke L; Hawkins LK; Hay C; Huang Y; Kaloss M; Marinov A; Phipps S; Pinkstaff A; Shirley P; Skripchenko Y; Stewart D; Forry-Schaudies S; Hallenbeck PL
    Cancer Res; 2003 Apr; 63(7):1490-9. PubMed ID: 12670895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective targeting of human cells by a chimeric adenovirus vector containing a modified fiber protein.
    Stevenson SC; Rollence M; Marshall-Neff J; McClelland A
    J Virol; 1997 Jun; 71(6):4782-90. PubMed ID: 9151872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The kinetics of VP5 mRNA expression is not critical for viral replication in cultured cells.
    Lieu PT; Wagner EK
    J Virol; 2000 Mar; 74(6):2770-6. PubMed ID: 10684293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Development of a novel adenovirus vector exhibiting microRNA-mediated suppression of the leaky expression of adenovirus genes].
    Shimizu K; Sakurai F; Tachibana M; Mizuguchi H
    Yakugaku Zasshi; 2012; 132(12):1407-12. PubMed ID: 23208048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adenovirus E4-dependent activation of the early E2 promoter is insufficient to promote the early-to-late-phase transition.
    Hemström C; Virtanen A; Bridge E; Ketner G; Pettersson U
    J Virol; 1991 Mar; 65(3):1440-9. PubMed ID: 1825341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of cell lines capable of complementing E1, E4, and protein IX defective adenovirus type 5 mutants.
    Krougliak V; Graham FL
    Hum Gene Ther; 1995 Dec; 6(12):1575-86. PubMed ID: 8664382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.